Absolutely stunning work: de novo designed miniproteins targeting GPCRs as potent agonists and antagonists.
This opens countless possibilities for programmable signaling, cleaner therapeutics, and faster drug discovery.
Protein design is coming for pharmacology. 🚀
doi.org/10.1038/s415...
doi.org
Nature - De novo design of miniproteins targeting GPCRs
